Treatment Approach for Post-Schizophrenic Depression

Initial Assessment and Antipsychotic Optimization

• Rule out secondary causes of depressive symptoms, including persistent positive symptoms, substance misuse, social isolation, medical illness, and medication side effects 1
• For patients with predominant negative symptoms where positive symptoms are controlled, low-dose amisulpride (50 mg twice daily) may be beneficial 1

Antidepressant Augmentation

• If depressive symptoms persist despite antipsychotic optimization, add an antidepressant to the antipsychotic regimen 1
• Offer psychosocial interventions to address psychological factors that might exacerbate or maintain depressive symptoms 1
• Encourage social engagement and support to reduce isolation, which can worsen depressive symptoms 1

Monitoring and Follow-up

• Evaluate treatment response after 4-6 weeks at adequate doses before determining efficacy 2

Treatment-Resistant Cases

• If depressive symptoms persist despite adequate trials of antipsychotic optimization and antidepressant augmentation, consider clozapine if not already prescribed 3, 4
• For patients already on clozapine with persistent depressive symptoms, consider augmentation with amisulpride or aripiprazole 1
• Electroconvulsive therapy may be beneficial in treatment-resistant cases, particularly when combined with clozapine 1